Welcome to our dedicated page for Alkami Technology SEC filings (Ticker: ALKT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Alkami Technology, Inc. (Nasdaq: ALKT) files reports with the U.S. Securities and Exchange Commission that provide insight into its operations, governance, and financial condition. This SEC filings page for ALKT brings together those regulatory documents and pairs them with AI-powered tools that help explain their contents in accessible language.
Alkami’s recent Form 8-K current reports illustrate the types of information investors can expect. One 8-K describes a press release announcing quarterly financial results and notes that the related information is furnished rather than filed. Another 8-K discusses the appointment of a new Chief Financial Officer, including a summary of her background and key terms of her employment agreement, such as compensation, equity awards, and severance provisions. A separate 8-K details the appointment of a new member of the board of directors, her committee assignments, and the determination that she is an independent director and qualifies as an audit committee financial expert.
On this page, users can review Alkami’s 10-K annual reports and 10-Q quarterly reports, along with 8-Ks and other filings, as they become available through EDGAR. AI-powered summaries highlight important sections, explain technical language, and surface key items such as segment discussions, risk factor updates, and major contracts or governance changes. For investors tracking governance and leadership, the filings also provide information about board composition, committee roles, and executive appointments.
In addition, this page offers streamlined access to insider transaction reports on Form 4, when filed, so users can monitor equity transactions by directors and officers. Real-time updates from EDGAR ensure that new Alkami filings appear promptly, while AI-generated overviews help readers understand how each document fits into the broader picture of ALKT’s regulatory and corporate history.
Alkami Technology (ALKT) filed its Q3 2025 10‑Q, reporting strong top-line growth with continued investment. Revenue for the quarter was $112.954 million, up from $85.906 million a year ago, while gross profit rose to $64.142 million. The company posted a net loss of $14.804 million, or $0.14 per share, as operating expenses increased to support product development, sales and the integration of recent acquisitions.
Alkami closed the MANTL acquisition in March for approximately $375 million (net of cash acquired), contributing $11.0 million of revenue in Q3. Remaining performance obligations were about $1.6 billion as of September 30, 2025, with 49.9% expected to be recognized over the next 24 months. The company issued $345 million of 1.50% convertible senior notes due 2030 and ended the quarter with $57.316 million in cash and cash equivalents, a $25 million revolver balance, and a net carrying amount of $335.717 million for the notes.
Year to date, revenue reached $322.848 million, and the business recorded an $11.6 million income tax benefit tied in part to a partial release of a valuation allowance associated with the MANTL transaction.
Alkami Technology (ALKT) appointed Cassandra Hudson as Chief Financial Officer, effective November 1, 2025. She succeeds Bryan Hill, who will retire on October 31, 2025 and serve as a consultant through December 15, 2026. The company also furnished a press release announcing financial results for the quarter ended September 30, 2025, and shared a CFO announcement and an investor presentation.
Ms. Hudson’s Employment Agreement includes an annual base salary of $460,000, a target bonus equal to 70% of base (prorated for 2025), a $25,000 signing bonus, and restricted stock units valued at $6,000,000 that vest in equal quarterly installments over four years. If terminated without “cause” or she resigns for “good reason,” severance includes 100% of base salary over 12 months and up to nine months of company‑paid healthcare; upon a qualifying change in control separation, severance includes 100% of base salary, 100% of target bonus plus a prorated target bonus over 12 months, up to 12 months of healthcare, and full vesting acceleration of equity awards.
Alkami Technology (ALKT) appointed Cassandra Hudson as Chief Financial Officer, effective November 1, 2025. She succeeds Bryan Hill, who will retire on October 31, 2025 and serve as a consultant through December 15, 2026. The company also furnished a press release announcing financial results for the quarter ended September 30, 2025, and shared a CFO announcement and an investor presentation.
Ms. Hudson’s Employment Agreement includes an annual base salary of $460,000, a target bonus equal to 70% of base (prorated for 2025), a $25,000 signing bonus, and restricted stock units valued at $6,000,000 that vest in equal quarterly installments over four years. If terminated without “cause” or she resigns for “good reason,” severance includes 100% of base salary over 12 months and up to nine months of company‑paid healthcare; upon a qualifying change in control separation, severance includes 100% of base salary, 100% of target bonus plus a prorated target bonus over 12 months, up to 12 months of healthcare, and full vesting acceleration of equity awards.
Brian R. Smith, a director and reported 10% owner of Alkami Technology, Inc. (ALKT), reported transactions dated 10/05/2025. He elected to defer receipt of 786 common shares under the company's 2021 Incentive Award Plan at a stated price of $0, which increased his directly held shares to 551,148. The filing also discloses 14,218,240 shares held indirectly by S3 Ventures Fund III, L.P., for which Mr. Smith may be deemed to have beneficial ownership through the fund and related entities; those entities disclaim beneficial ownership except to the extent of pecuniary interest. Signatures show the filing was executed on 10/07/2025.
Insider transaction summary: A Form 4 shows director Steven R. Mitchell reported an acquisition of 347 shares of Alkami Technology, Inc. (ALKT) on 10/05/2025, with an elected deferral under the 2021 Incentive Award Plan, priced at $0 to reflect the deferred issuance terms. The filing also discloses an indirect beneficial interest in 2,521,611 shares held by ARG Private Equity II, LLC (APE II), for which Mr. Mitchell serves as an adviser and disclaims beneficial ownership except for his pecuniary interest. The Form 4 was signed by an attorney-in-fact on 10/07/2025.
Insider transaction summary: A Form 4 filed for ALKAMI TECHNOLOGY, INC. (ALKT) reports that director Maria Ines Alvarez acquired 223 shares of common stock on 10/05/2025. The transaction is coded V, indicating shares issued upon vesting, and the reported price is $0, consistent with issuance of vested restricted stock rather than an open‑market purchase. After the transaction, Ms. Alvarez beneficially owns 57,623 shares. The form is signed by an attorney‑in‑fact on 10/07/2025.
Alex Shootman, Alkami Technology's Chief Executive Officer and a director, reported a sale of 42,930 shares of Alkami common stock at $25.66 per share to satisfy tax withholding obligations tied to the vesting and settlement of restricted stock units (RSUs). After the reported sale the reporting person beneficially owned 796,563 shares. The Form 4 states the transaction was a "sell to cover" to fund tax withholding and was not a discretionary sale by the reporting person.
Prerna Sachdeva, Chief Accounting Officer of Alkami Technology, Inc. (ALKT), reported a routine insider sale on a Form 4. The filing shows a disposition of 2,967 shares of Alkami common stock on 09/02/2025 at a price of $24.76 per share. The sale was executed as a "sell-to-cover" to satisfy tax withholding obligations arising from the vesting and settlement of restricted stock units. Following the transaction, the reporting person beneficially owns 66,061 shares. The Form 4 was signed by an attorney-in-fact and filed with the SEC.
Douglas A. Linebarger, Chief Legal Officer of Alkami Technology, Inc. (ALKT), reported a non-discretionary sale of 8,242 shares of common stock on 09/02/2025 at a price of $24.76 per share. The filing states the shares were sold to satisfy tax withholding obligations arising from the vesting and settlement of restricted stock units (RSUs) and were executed as a "sell to cover" rather than a voluntary trade. After the transaction the reporting person beneficially owned 229,930 shares directly. The Form 4 was signed on 09/04/2025 and was filed by one reporting person.
W. Bryan Hill, Chief Financial Officer and director of Alkami Technology, Inc. (ALKT), reported the sale of 20,366 shares of the company's common stock on 09/02/2025 at a price of $24.76 per share. The filing shows the transaction was a "sell-to-cover" to satisfy tax withholding on vested RSUs and was not a discretionary sale by the reporting person. After the transaction, the reporting person beneficially owned 409,889 shares. The Form 4 discloses standard insider reporting details and clarifies the sale's purpose as tax-related rather than an open-market liquidity decision.
Alex Shootman, Chief Executive Officer and a director of Alkami Technology, Inc. (ALKT), reported a sale of 75,000 shares of common stock on 08/27/2025, at a weighted-average price of $25.1954 per share (individual trade prices ranged from $24.84 to $25.36). After the reported sale, the reporting person beneficially owned 839,493 shares. The filing states the sales were effected pursuant to a Rule 10b5-1 trading plan, and the filer offers to provide details on the number of shares sold at each price within the reported range upon request.